Drug-Coated Balloons Versus Drug-Eluting Stents or Plain Old Balloon Angioplasty: A Long-Term in-Stent Restenosis StudyShow others and affiliations
2024 (English)In: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, E-ISSN 2047-9980, Vol. 13, no 23, article id e036839
Article in journal (Refereed) Published
Abstract [en]
Background Balloon angioplasty with drug-coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in-stent restenosis. Despite its frequent use, there is a lack of long-term data on the efficacy of DCB angioplasty. We conducted an investigation on the long-term efficacy outcome of in-stent restenosis, comparing DCBs, drug-eluting stents, and plain old balloon angioplasty.Methods and Results We conducted a nationwide analysis from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) including in-stent restenosis lesions undergoing coronary angiography between June 11, 2013, and January 14, 2022. The primary outcome of this study was target-lesion revascularization within a 5-year follow-up. Secondary outcomes included all-cause death, cardiovascular death, myocardial infarction, and any percutaneous coronary intervention. The outcomes were analyzed using a multivariable Cox proportional hazard model or Poisson regression, as appropriate. A total of 10 561 lesions from 9062 patients were included. Compared with plain old balloon angioplasty, the use of DCB angioplasty was associated with less target-lesion revascularization (risk ratio, 0.69 [95% CI, 0.57-0.82]), all-cause death (risk ratio, 0.72 [95% CI, 0.59-0.88]), and cardiovascular death (hazard ratio [HR], 0.59 [95% CI, 0.45-0.78]). No difference was observed for myocardial infarction or any percutaneous coronary intervention. Compared with drug-eluting stents, the use of DCBs was associated with higher rates of target-lesion revascularization (HR, 1.20 [95% CI, 1.06-1.37]). No difference was observed for all-cause death, cardiovascular death, myocardial infarction, or any percutaneous coronary intervention.Conclusions In this long-term nationwide analysis, the use of DCB angioplasty showed superior outcomes compared with plain old balloon angioplasty within 5 years but higher rates of repeat revascularizations compared with drug-eluting stents.
Place, publisher, year, edition, pages
WILEY , 2024. Vol. 13, no 23, article id e036839
Keywords [en]
drug-coated balloon; drug-eluting stent; in-stent restenosis; plain old balloon angioplasty; target-lesion revascularization
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:liu:diva-210459DOI: 10.1161/JAHA.124.036839ISI: 001368270400001PubMedID: 39575722Scopus ID: 2-s2.0-85211660276OAI: oai:DiVA.org:liu-210459DiVA, id: diva2:1921748
Note
Funding Agencies|Swedish Heart and Lung Foundation; ALF; Skane University Hospital funds; Maerta Winkler Foundation; Thorsten Westerstroems Foundation; Sven- Eric Lundgren Foundation for Medical Research; Crafoord Foundation; Swedish Medical Association
2024-12-172024-12-172025-05-05